Research of shRNAmir inhibitory effects towards focal adhesion kinase expression in the treatment of gastric cancer

Su,Guo‑Qiang; Zhang,Fu‑Xing; Mao,He‑Hui; Liu,Xian‑Wei; Zheng,Yong‑Sheng; Zhang,Si‑Yu; Su,Jing‑Jun

doi:10.3892/ol.2014.2725

Research of shRNAmir inhibitory effects towards focal adhesion kinase expression in the treatment of gastric cancer

Authors:
- Guo‑Qiang Su
- Fu‑Xing Zhang
- He‑Hui Mao
- Xian‑Wei Liu
- Yong‑Sheng Zheng
- Si‑Yu Zhang
- Jing‑Jun Su
View Affiliations

Affiliations: Department of General Surgery, The First Affiliated Hospital, Xiamen University, Xiamen, Fujian 361003, P.R. China, Department of Ultrasound Diagnosis, The First Affiliated Hospital, Xiamen University, Xiamen, Fujian 361003, P.R. China
Published online on: November 21, 2014 https://doi.org/10.3892/ol.2014.2725
Pages: 595-603
Copyright: © Su et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric cancer is the fourth most common type of malignant tumor, with a poor prognosis. Focal adhesion kinase (FAK) mediates the crosslink of intracellular signaling networks, playing a key role in cell migration and invasion. The aim of the present study was to investigate the effects of FAK interference on the proliferation ability, invasion and metastasis of gastric cancer cells. The FAK‑RNAi lentiviral vector was infected into SGC7901 gastric cancer cells in order to observe the in vivo situations of tumor growth and metastasis before and after the FAK interference. The growth of SGC7901 gastric cancer cells in the interference group was significantly inhibited compared with that of the negative control (P<0.05) and the blank control groups (P<0.05), and the FAK expression significantly decreased (P<0.05). The in vitro invasion and metastasis experiments showed that the cell invasion and metastasis abilities of the interference group significantly decreased when compared with those of the negative control (P<0.05) and blank control groups (P<0.05). In the nude mouse subcutaneous tumor transplantation model, the mean ± standard deviation tumor weight of the interference group (1.474±0.9840 g) was lower than that of the negative control (3.134±0.3299 g) and blank control (2.68±0.12 g) groups (P<0.05). In the nude mice, the liver and peritoneal metastasis rates of the interference group were significantly lower than those of the negative control (P<0.05) and the blank control groups (P<0.05), and the FAK mRNA of the interference group significantly reduced (P<0.05). In conclusion, FAK interference could effectively suppress the proliferation, invasion and metastasis of transfected SGC7901 gastric cancer cells, and could inhibit the growth and distant metastasis of gastric cancer in nude mice.

View Figures

View References

1	Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
2	Thomassen I, van Gestel YR, van Ramshorst B, et al: Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 134:622–628. 2013. View Article : Google Scholar : PubMed/NCBI
3	Chiang CY, Huang KH, Fang WL, et al: Factors associated with recurrence within 2 years after curative surgery for gastric adenocarcinoma. World J Surg. 35:2472–2478. 2011. View Article : Google Scholar : PubMed/NCBI
4	Brancato S and Miner TJ: Surgical management of gastric cancer: review and consideration for total care of the gastric cancer patient. Curr Treat Options Gastroenterol. 11:109–118. 2008. View Article : Google Scholar : PubMed/NCBI
5	Leung WK, Wu MS, Kakugawa Y, et al; Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 9:279–287. 2008. View Article : Google Scholar : PubMed/NCBI
6	Xie ZJ, Liu Y, Jia LM and He YC: Heparanase expression, degradation of basement membrane and low degree of infiltration by immunocytes correlate with invasion and progression of human gastric cancer. World J Gastroentero. 14:3812–3818. 2008. View Article : Google Scholar
7	Su JM, Gui L, Zhou YP and Zha XL: Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance. World J Gastroenterol. 8:613–618. 2002.PubMed/NCBI
8	Golubovskaya VM, Ho B, Zheng M, et al: Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth. BMC Cancer. 13:3422013. View Article : Google Scholar : PubMed/NCBI
9	Hao HF, Naomoto Y, Bao XH, et al: Progress in researches about focal adhesion kinase in gastrointestinal tract. World J Gastroenterol. 15:5916–5923. 2009. View Article : Google Scholar : PubMed/NCBI
10	Park JH, Lee BL, Yoon J, et al: Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer. Hum Pathol. 41:1664–1673. 2010. View Article : Google Scholar : PubMed/NCBI
11	Wu Z, Li X, Sunkara M, et al: PIPKIγ regulates focal adhesion dynamics and colon cancer cell invasion. PLoS One. 6:e247752011. View Article : Google Scholar
12	Kamo N, Naomoto Y, Shirakawa Y, et al: Involvement of focal adhesion kinase in the progression and prognosis of gastrointestinal stromal tumors. Hum Pathol. 40:1643–1649. 2009. View Article : Google Scholar : PubMed/NCBI
13	Dy GK: The role of focal adhesion kinase in lung cancer. Anticancer Agents Med Chem. 13:581–583. 2013. View Article : Google Scholar
14	Mitra SK, Lim ST, Chi A and Schlaepfer DD: Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model. Oncogene. 25:4429–4440. 2006. View Article : Google Scholar : PubMed/NCBI
15	Dassie JP, Liu XY, Thomas GS, et al: Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat Biotechnol. 27:839–849. 2009. View Article : Google Scholar : PubMed/NCBI
16	Zagzag D, Friedlander DR, Margolis B, et al: Molecular events implicated in brain tumor angiogenesis and invasion. Pediatr Neurosurg. 33:49–55. 2000. View Article : Google Scholar : PubMed/NCBI
17	Liu B, Huang J, Zhou Y, et al: Lentivirus-mediated LOX-1-RNA interference attenuates oxidative stress-induced apoptosis in myocardial cells. Nan Fang Yi Ke Da Xue Xue Bao. 32:165–168. 2012.(In Chinese). PubMed/NCBI
18	Tan TW, Yang WH, Lin YT, et al: Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells. Carcinogenesis. 30:258–268. 2009. View Article : Google Scholar : PubMed/NCBI
19	Ren K, Jin H, Bian C, et al: MR-1 modulates proliferation and migration of human hepatoma HepG2 cells through myosin light chains-2 (MLC2)/focal adhesion kinase (FAK)/Akt signaling pathway. J Biol Chem. 283:35598–35605. 2008. View Article : Google Scholar : PubMed/NCBI
20	Sonoda Y, Hada N, Kaneda T, et al: A synthetic glycosphingolipid-induced antiproliferative effect in melanoma cells is associated with suppression of FAK, Akt, and Erk activation. Biol Pharm Bull. 31:1279–1283. 2008. View Article : Google Scholar : PubMed/NCBI
21	Hauck CR, Sieg DJ, Hsia DA, Loftus JC, Gaarde WA, Monia BP and Schlaepfer DD: Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res. 61:7079–7090. 2001.PubMed/NCBI
22	Li S, Dong W, Zong Y, et al: Polyethylenimine-complexed plasmid particles targeting focal adhesion kinase function as melanoma tumor therapeutics. Mol Ther. 15:515–523. 2007. View Article : Google Scholar : PubMed/NCBI
23	Megison ML, Stewart JE, Nabers HC, et al: FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma. Clin Exp Metastasis. 30:555–568. 2013. View Article : Google Scholar :
24	Tsutsumi K, Kasaoka T, Park HM, et al: Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase. Int J Oncol. 33:215–224. 2008.PubMed/NCBI
25	Nakanishi H, Yasui K, Ikehara Y, et al: Establishment and characterization of three novel human gastric cancer cell lines with differentiated intestinal phenotype derived from liver metastasis. Clin Exp Metastasis. 22:137–147. 2005. View Article : Google Scholar : PubMed/NCBI
26	Mei LJ, Yang XJ, Tang L, et al: Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer. BMC Cancer. 10:1242010. View Article : Google Scholar : PubMed/NCBI